Catalyst Wire Dossier Catalyst Wire Dossier

Bortezomib Hospira

bortezomib · Pfizer Europe MA EEIG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bortezomib Hospira, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: EMA Withdrawn: Bortezomib Hospira (bortezomib) — Pfizer Europe MA EEIG

See pricing